(Total Views: 922)
Posted On: 06/05/2023 6:03:07 PM
Post# of 155891
“The leading Metastatic Triple-Negative Breast Cancer Companies include G1 Therapeutics, CytoDyn, Merck, Gilead Sciences, AstraZeneca, Hoffmann-La Roche, Celegene, and Others“
Nice to see us mentioned.
https://www.abnewswire.com/pressreleases/navi...54171.html
Nice to see us mentioned.
https://www.abnewswire.com/pressreleases/navi...54171.html


Daniel Rizzo
Federal Whistleblower / Special Operations Tactical Unit
USAF: Phoenix Raven #2143
HHS & SEC Whistleblower: HL-1412396
DOJ Investigation Report/ Whistleblower ID: 20250705-0001
NIH Case Reference: CS1137565
Founder & CEO of FireGate Bioscience
USPTO: Lead Inventor of the HIV Cure & AI Federal Oversight Program
⸻
Public Links
FireGate Bioscience: https://www.firegatebioscience.com
NotYourDrug.com: https://www.notyourdrug.com
Federal Whistleblower / Special Operations Tactical Unit
USAF: Phoenix Raven #2143
HHS & SEC Whistleblower: HL-1412396
DOJ Investigation Report/ Whistleblower ID: 20250705-0001
NIH Case Reference: CS1137565
Founder & CEO of FireGate Bioscience
USPTO: Lead Inventor of the HIV Cure & AI Federal Oversight Program
⸻
Public Links
FireGate Bioscience: https://www.firegatebioscience.com
NotYourDrug.com: https://www.notyourdrug.com